Drugs / Progesterone vaginal insert
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00805935 | Jan 2009 → Jul 2010 | infertility disorder, polycystic ovary syndrome | Ferring Pharmaceuticals | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Progesterone vaginal insert | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00805935 ↗ |
| Known as | PVI | “This report describes the administration preferences expressed by women with infertility that were given progesterone vaginal insert (PVI) or progesterone in oil injections...” PMID 25385669 ↗ Nov 2014 |